Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.

scientific article published in May 1996

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00007435-199605000-00013
P698PubMed publication ID8724515

P2093author name stringSapp M
Schiller J
Dillner J
Andersson-Ellström A
Milsom I
Forssman L
Hagmar B
P433issue3
P921main subjectantibodyQ79460
P304page(s)234-238
P577publication date1996-05-01
P1433published inSexually Transmitted DiseasesQ15763556
P1476titleComparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.
P478volume23

Reverse relations

cites work (P2860)
Q36645918A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
Q71733553A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears
Q36609068Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review
Q35566274Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination
Q36542076Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA
Q36376205Genital human papillomavirus (HPV) concordance in heterosexual couples.
Q50535432HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.
Q50537413Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.
Q33736749Human papillomavirus infection in adolescents
Q34305225Immunity to oncogenic human papillomaviruses
Q35562265Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection
Q41103016Immunology of papillomavirus infection.
Q40833121Intraepithelial carcinoma of the cervix: reflections on half a century of progress
Q45722771Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
Q37137430New Approaches to Immunotherapy for HPV Associated Cancers
Q50857924Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
Q37001336Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis
Q33974260Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes
Q73223002Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia
Q51871486Seroepidemiology as basis for design of a human papillomavirus vaccination program.
Q45744835Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus
Q45733679Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer
Q33936598Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA
Q34310582Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women
Q36671130Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
Q36539107Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland
Q37855949Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
Q36641617Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection
Q56959542Strategies for immunoprophylaxis and immunotherapy of papillomaviruses
Q39727597The first international standard for antibodies to HPV 16.
Q45103275Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
Q34089060Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection

Search more.